Heather Landau
MD
Associate Attending Physician, Myeloma Service
👥Biography 个人简介
Heather Landau played a key role in clinical trials evaluating daratumumab in AL amyloidosis, including the landmark ANDROMEDA trial that demonstrated superior hematologic response rates with daratumumab plus bortezomib, cyclophosphamide, and dexamethasone (VCd) compared to VCd alone, leading to FDA approval. Her research spans autologous stem cell transplantation and novel agent combinations for amyloidosis, with attention to organ response endpoints.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Heather Landau 的研究动态
Follow Heather Landau's research updates
留下邮箱，当我们发布与 Heather Landau（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment